ARTICLE | Company News
Athera, Dyax deal
October 6, 2008 7:00 AM UTC
The companies will partner to discover and develop antibodies against phosphorylcholine (PC) to prevent or treat cardiovascular diseases such as atherosclerosis. Dyax will use its antibody libraries ...